Related Experiment Video
Updated: May 30, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
Published on: December 30, 2025
Identification of Differentially Expressed MicroRNAs in Osteosarcoma
Rishi R Lulla1, Fabricio F Costa, Jared M Bischof
1Division of Hematology, Oncology and Stem Cell Transplantation, Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614, USA.
Abstract:
A limited number of reports have investigated the role of microRNAs in osteosarcoma. In this study, we performed miRNA expression profiling of osteosarcoma cell lines, tumor samples, and normal human osteoblasts. Twenty-two differentially expressed microRNAs were identified using high throughput real-time PCR analysis, and 4 (miR-135b, miR-150, miR-542-5p, and miR-652) were confirmed and validated in a different group of tumors. Both miR-135b and miR-150 have been previously shown to be important in cancer. We hypothesize that dysregulation of differentially expressed microRNAs may contribute to tumorigenesis. They might also represent molecular biomarkers or targets for drug development in osteosarcoma.
Insights
This study identified 22 differentially expressed microRNAs in osteosarcoma, with four validated as potential biomarkers. These microRNAs may play a role in osteosarcoma development and offer targets for new therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Limited research exists on microRNA roles in osteosarcoma.
- MicroRNAs are small non-coding RNAs that regulate gene expression.
- Dysregulation of microRNAs is implicated in various cancers.
Purpose of the Study:
- To investigate microRNA expression profiles in osteosarcoma.
- To identify differentially expressed microRNAs in osteosarcoma cell lines and tumors.
- To explore the potential of microRNAs as biomarkers and therapeutic targets for osteosarcoma.
Main Methods:
- MicroRNA expression profiling using high-throughput real-time PCR.
- Analysis of osteosarcoma cell lines, tumor samples, and normal human osteoblasts.
- Validation of candidate microRNAs in an independent tumor cohort.
Main Results:
- Twenty-two microRNAs showed differential expression in osteosarcoma.
- Four microRNAs (miR-135b, miR-150, miR-542-5p, miR-652) were confirmed and validated.
- miR-135b and miR-150 have known roles in cancer, suggesting their involvement in osteosarcoma.
Conclusions:
- Dysregulated microRNAs are potentially involved in osteosarcoma tumorigenesis.
- Identified microRNAs may serve as valuable molecular biomarkers for osteosarcoma.
- These microRNAs represent potential targets for novel drug development in osteosarcoma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs

